Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page
- Check2 days agoChange DetectedClinicalTrials.gov’s page footer revision tag was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the study details.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.5.2 is now shown, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded results-related data to the Study Record Dates, including Results First Posted 2025-10-29. Updated associated dates to reflect new published outcomes.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision metadata updated to v3.5.0. The previous v3.4.3 entry was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows a minor update to the study protocol/document version from v3.4.1 to v3.4.2, with no visible changes to study information.SummaryDifference0.1%

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.